From: Efficacy of surgical methods for peri-implantitis: a systematic review and network meta-analysis
Publication | Country | Follow-up times (months) | Participant age (years) | Control group | Test group | Number of intervention and comparison | Outcomes |
---|---|---|---|---|---|---|---|
Renvert S (2021) [39] | Sweden, France, Germany | 12 | CG: 62.9 ± 13.0 TG: 62.2 ± 10.2 | OFD | AT | 32/34 | BL/PD/BI/SUP/REC |
Cha JK (2019) [44] | South Korea | 6 | 61.6 ± 21.6 | OFD | OFD + LA | 25/25 | PD/PI/GI |
Renvert S (2018) [40] | Sweden | 12 | CG: 70 ± 7.8 TG: 67.5 ± 11.3 | OFD | AT | 20/21 | PD/BL |
Isler SC (2018) [49] | Turkey | 12 | CG: 54.18 ± 10.36 TG: 54.4 ± 8.08 | AT | AT + O | 21/20 | PI/GI/BOP/PD/CAL/REC/VDD |
Albaker AM (2018) [45] | Saudi Arabia | 12 | CG: 61.5 ± 9.9 TG: 58.4 ± 8.0 | OFD | OFD + PDT | 13/11 | PI/BOP/PD/BL |
Hentenaar DFM (2017) [47] | Netherlands | 3 | CG: 57.0 ± 13.7 TG: 60.9 ± 7.2 | RT | RT + PA | 20/30 | BOP/SUP/PD |
Rakašević D (2016) [48] | Serbia | 3 | CG: 60 TG: 57.59 | AT | AT + PDT | 19/21 | PD/CAL/BOP |
Jepsen K (2016) [41] | Germany | 12 | 58.4 ± 12.3 | OFD | AT | 26/33 | VDD/PD/BOP/PI |
Hamzacebi B (2015) [42] | Turkey | 6 | 60.98 ± 11.9 | OFD | AT | 19/19 | BOP/PD/REC/CAL/KM |
Bombeccari GP (2013) [46] | Italy | 6 | 46 ± 13.0 | OFD | OFD + PDT | 20/20 | PD/CAL/BOP |
Wohlfahrt JC (2012) [50] | Norway | 12 | CG: 65.0 ± 10.0 TG: 57.2 ± 12.3 | OFD | RT | 16/16 | PD/BOP |
Emanuel N (2012) [43] | Israel | 12 | 64.81 ± 7.61 | OFD | AT | 14/18 | PD/CAL/BL/BOP/REC |
Lasserre JF (2020) [51] | Belgium | 6 | 66.5 ± 24.5 | RT | OFD | 15/14 | PI/BOP/SOP/PD/CAL/REC/BL |